For diagnosis, a composite model integrating fecal abundance of specific microbes (e.g., Faecalicoccus) with plasma levels of specific immune cells (e.g., CD19+IgD+CD38bright B cells) could facilitate noninvasive risk stratification for glioma, potentially identifying high‐risk individuals before radiological detection. Here, CD19 is linked to glioma.